CLBS Annual Operating Expenses
$29.05 M
+$9.90 M+51.74%
31 December 2021
Summary:
As of January 29, 2025, CLBS annual total operating expenses is $29.05 million, with the most recent change of +$9.90 million (+51.74%) on December 31, 2021. During the last 3 years, it has risen by +$12.06 million (+71.01%).CLBS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Quarterly Operating Expenses
$37.72 M
+$31.00 M+461.31%
01 September 2022
Summary:
As of January 29, 2025, CLBS quarterly total operating expenses is $37.72 million, with the most recent change of +$31.00 million (+461.31%) on September 1, 2022. Over the past year, it has increased by +$30.75 million (+441.33%).CLBS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.7% | +441.3% |
| 3 y3 years | +71.0% | +643.7% |
| 5 y5 years | +5.3% | +515.3% |
CLBS Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -51.6% | at high |
Caladrius Biosciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $37.72 M(+461.3%) |
| June 2022 | - | $6.72 M(+1.5%) |
| Mar 2022 | - | $6.62 M(-3.3%) |
| Dec 2021 | $29.05 M(+51.7%) | $6.85 M(-1.7%) |
| Sept 2021 | - | $6.97 M(-2.5%) |
| June 2021 | - | $7.15 M(-11.6%) |
| Mar 2021 | - | $8.09 M(+48.5%) |
| Dec 2020 | $19.14 M(-4.7%) | $5.45 M(+1.8%) |
| Sept 2020 | - | $5.35 M(+24.7%) |
| June 2020 | - | $4.29 M(+5.8%) |
| Mar 2020 | - | $4.06 M(-20.2%) |
| Dec 2019 | $20.09 M(+18.3%) | $5.08 M(+0.2%) |
| Sept 2019 | - | $5.07 M(-5.1%) |
| June 2019 | - | $5.35 M(+16.4%) |
| Mar 2019 | - | $4.59 M(+21.0%) |
| Dec 2018 | $16.99 M(-38.4%) | $3.80 M(+0.9%) |
| Sept 2018 | - | $3.76 M(-11.9%) |
| June 2018 | - | $4.27 M(-17.3%) |
| Mar 2018 | - | $5.16 M(-29.5%) |
| Dec 2017 | $27.59 M(-6.5%) | $7.32 M(+19.4%) |
| Sept 2017 | - | $6.13 M(-20.5%) |
| June 2017 | - | $7.71 M(+19.9%) |
| Mar 2017 | - | $6.43 M(+17.1%) |
| Dec 2016 | $29.50 M(-45.3%) | $5.49 M(-4.1%) |
| Sept 2016 | - | $5.73 M(-22.7%) |
| June 2016 | - | $7.41 M(-40.0%) |
| Mar 2016 | - | $12.33 M(+50.2%) |
| Dec 2015 | $53.90 M(-10.2%) | $8.21 M(-28.3%) |
| Sept 2015 | - | $11.46 M(-29.8%) |
| June 2015 | - | $16.34 M(-8.7%) |
| Mar 2015 | - | $17.89 M(+7.4%) |
| Dec 2014 | $60.00 M(+55.7%) | $16.67 M(+1.8%) |
| Sept 2014 | - | $16.36 M(+23.6%) |
| June 2014 | - | $13.24 M(-3.5%) |
| Mar 2014 | - | $13.73 M(+22.3%) |
| Dec 2013 | $38.53 M(+17.6%) | $11.23 M(+11.8%) |
| Sept 2013 | - | $10.04 M(+21.1%) |
| June 2013 | - | $8.29 M(-7.5%) |
| Mar 2013 | - | $8.96 M(+9.5%) |
| Dec 2012 | $32.77 M(-7.5%) | $8.18 M(-6.7%) |
| Sept 2012 | - | $8.78 M(+17.8%) |
| June 2012 | - | $7.45 M(-10.9%) |
| Mar 2012 | - | $8.36 M(-1.2%) |
| Dec 2011 | $35.41 M(-8.0%) | $8.46 M(+12.5%) |
| Sept 2011 | - | $7.52 M(-28.1%) |
| June 2011 | - | $10.46 M(-15.6%) |
| Mar 2011 | - | $12.39 M(+24.9%) |
| Dec 2010 | $38.47 M | $9.92 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $10.99 M(+9.9%) |
| June 2010 | - | $10.00 M(+31.7%) |
| Mar 2010 | - | $7.59 M(-45.5%) |
| Dec 2009 | $27.73 M(+198.6%) | $13.92 M(+91.6%) |
| Sept 2009 | - | $7.26 M(+54.0%) |
| June 2009 | - | $4.72 M(+151.3%) |
| Mar 2009 | - | $1.88 M(-23.3%) |
| Dec 2008 | $9.29 M(-12.8%) | $2.45 M(+26.3%) |
| Sept 2008 | - | $1.94 M(-18.6%) |
| June 2008 | - | $2.38 M(-5.7%) |
| Mar 2008 | - | $2.52 M(+1.7%) |
| Dec 2007 | $10.65 M(+125.8%) | $2.48 M(-42.6%) |
| Sept 2007 | - | $4.33 M(+120.7%) |
| June 2007 | - | $1.96 M(+4.7%) |
| Mar 2007 | - | $1.87 M(+7.9%) |
| Dec 2006 | $4.71 M(+192.6%) | $1.74 M(+73.6%) |
| Sept 2006 | - | $999.80 K(-3.8%) |
| June 2006 | - | $1.04 M(+10.7%) |
| Mar 2006 | - | $939.20 K(+90.7%) |
| Dec 2005 | $1.61 M(+8.2%) | $492.50 K(-9.6%) |
| Sept 2005 | - | $544.60 K(+51.8%) |
| June 2005 | - | $358.80 K(+66.5%) |
| Mar 2005 | - | $215.50 K(-19.0%) |
| Dec 2004 | $1.49 M(+62.7%) | $266.00 K(-36.4%) |
| Sept 2004 | - | $418.40 K(+0.7%) |
| June 2004 | - | $415.50 K(+6.8%) |
| Mar 2004 | - | $389.10 K(+3.5%) |
| Dec 2003 | $915.40 K(-21.8%) | $376.00 K(+86.8%) |
| Sept 2003 | - | $201.30 K(-3.9%) |
| June 2003 | - | $209.50 K(+62.9%) |
| Mar 2003 | - | $128.60 K(-64.5%) |
| Dec 2002 | $1.17 M(-28.8%) | $362.30 K(+57.0%) |
| Sept 2002 | - | $230.80 K(+12.3%) |
| June 2002 | - | $205.50 K(-44.7%) |
| Mar 2002 | - | $371.40 K(-21.6%) |
| Dec 2001 | $1.64 M(-34.6%) | $474.00 K(+22.4%) |
| Sept 2001 | - | $387.40 K(+7.8%) |
| June 2001 | - | $359.30 K(-14.9%) |
| Mar 2001 | - | $422.20 K(-38.6%) |
| Dec 2000 | $2.51 M(+145.5%) | $687.90 K(-34.0%) |
| Sept 2000 | - | $1.04 M(+112.8%) |
| June 2000 | - | $490.20 K(+63.6%) |
| Mar 2000 | - | $299.70 K |
| Dec 1999 | $1.02 M(+138.8%) | - |
| Dec 1998 | $428.20 K(+93.2%) | - |
| Mar 1998 | $221.60 K(-11.9%) | - |
| Mar 1997 | $251.60 K(-2.1%) | - |
| Mar 1996 | $257.10 K | - |
FAQ
- What is Caladrius Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Caladrius Biosciences?
- What is Caladrius Biosciences annual operating expenses year-on-year change?
- What is Caladrius Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Caladrius Biosciences?
- What is Caladrius Biosciences quarterly operating expenses year-on-year change?
What is Caladrius Biosciences annual total operating expenses?
The current annual operating expenses of CLBS is $29.05 M
What is the all time high annual operating expenses for Caladrius Biosciences?
Caladrius Biosciences all-time high annual total operating expenses is $60.00 M
What is Caladrius Biosciences annual operating expenses year-on-year change?
Over the past year, CLBS annual total operating expenses has changed by +$9.90 M (+51.74%)
What is Caladrius Biosciences quarterly total operating expenses?
The current quarterly operating expenses of CLBS is $37.72 M
What is the all time high quarterly operating expenses for Caladrius Biosciences?
Caladrius Biosciences all-time high quarterly total operating expenses is $37.72 M
What is Caladrius Biosciences quarterly operating expenses year-on-year change?
Over the past year, CLBS quarterly total operating expenses has changed by +$30.75 M (+441.33%)